Authors No. of patients Tumor size (cm) Image guidance Microwave frequency (MHz) Output power (W) Follow-up period (month) Complete ablation (%) Local treatment response (%) Survival rate 1 2 3…
Author Design Patients (HR vs ablation) Tumor size (cm) Recurrence Survival Complication Xu et al. [16] Meta-analysis 1233 vs 1302 ≤5 Lower for HR Higher for HR Higher for HR…
Fig. 20.1 Procedures of microwave ablation (MWA) in a 50-year-old woman with recrudescent pheochromocytoma, who had undergone surgical resection for right pheochromocytoma (size, 10 × 8 × 6 cm). (a) Six months after the…
, Xiao-ling Yu1 , Ping Liang1, Zhigang Cheng1, Zhiyu Han1, Fangyi Liu1 and Jie Yu1 (1) Department of Intentional Ultrasound, Chinese Liberation Army General Hospital, 28 Fuxing Road, Beijing, 100853, China Xiao-ling Yu Email: Dyuxl301@aliyun.cn …
Fig. 23.1 A 39-year-old woman who suffered from adenomyosis for about 5 years, with visual analogue scale (VAS) of 10, hemoglobin 106 g/l. Her uterine size was 11.5 cm × 9.0 cm × 11.3…
Fig. 31.1 Images in a 53-year-old female with a renal clear cell carcinoma (RCC) (4.8 cm × 4.5 cm) in the right kidney treated with microwave ablation (MWA). (a) Pre-ablation contrast-enhanced ultrasound…
Fig. 29.1 Images in a 58-year-old man who underwent contrast-enhanced ultrasound (CEUS) guidance microwave ablation (MWA) of hepatocellular carcinoma (HCC). (a) Contrast-enhanced computed tomography (CT) shows a local nodule (arrows)…
Fig. 19.1 Ultrasound-guided percutaneous microwave ablation (MWA) in a 47-year-old female patient with thyroid oxyphilic adenoma with a volume of 3.3 ml. The nodule is on the right thyroid lobe….
Fig. 13.1 Images in a 58-year-old man with 1.8 cm hepatocellular carcinoma treated by percutaneous microwave ablation (MWA) with artificial pleural effusion. (a) Contrast-enhanced magnetic resonance imaging (MRI) before MWA…
Author Patients System Tumor size (cm) Follow-up (months) CA (%) LTP (%) Five-year survival (%) Major complication (%) Seki et al. [7] 18 Microtaze <2 11–33 100 0 N/A 0…
